Why is it important to get your prostate checked after crossing 50? Expert explains how simple tests can help prevent cancer.

Results of a multicenter clinical trial found that adding the investigational adenoviral-based viral immunotherapy aglatimagene besadenovec (alglatimagene, CAN-2409) to standard radiation therapy improved disease-free survival for patients with intermediate- or high-risk localized prostate cancer.

(WISH) — The American Cancer Society reports that about one in eight men will be diagnosed with prostate cancer in their lifetime. The average age of men who get diagnosed is 67. Today, less than 1% of the 3.5 million men living with prostate cancer are ...

Staging means finding out how far prostate cancer has spread in your body. Physicians group prostate cancers into stages I (1) through IV (4), with stage I being the least advanced and stage IV being the most advanced. When your Fred Hutch Cancer Center ...

Peer reviewed publication details pivotal data, demonstrating 30% improvement in disease-free survival (DFS) in patients with localized prostate cancer undergoing standard-of-care radiotherapy with curative intent combined with aglatimagene besadenovec (aglatimagene) plus valacyclovir compared to placebo plus valacyclovir Findings support that addition of aglatimagene to standard-of-care radiotherapy can provide a meaningful benefit without increasing clinically significant toxicity     Data reported in this publication will support planned Biologics License Application (BLA) submission for aglatimagene in fourth quarter of 2026 NEEDHAM,

Using de-identified data from the National Cancer Institute, researchers followed 205 patients—average age, 61 years—with prostate cancer and preexisting depression. Patients with both conditions had significantly lower rates of overall survival versus ...

Prostate cancer rates have risen in recent years, with a sharp increase in cases diagnosed in advanced stages, the American Cancer Society said Tuesday. Diagnoses of prostate cancer rose 3% annually starting in 2014, after declining 6.4% per year in the ...

NORFOLK, Va. — Prostate cancer is the second-most deadly cancer among men in the United States. Rates are rising and experts are not sure why. But there is good news: when detected early, prostate cancer is highly treatable. The five-year survival rate ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society. In the US, advanced prostate cancer diagnoses have risen and racial disparities persist, highlighting the ...